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Objective. This study aimed to investigate whether propofol pretreatment can protect against liver transplantation-induced acute
lung injury (ALI) and to explore whether Nrf2 pathway is involved in the protections provided by propofol pretreatment.Method.
Adult male Sprague-Dawley rats were divided into five groups based on the random number table. Lung pathology was observed by
optical microscopy. Lung water content was assessed by wet/dry ratio, and PaO
2
was detected by blood gas analysis.The contents of
H
2
O
2
,MDA, and SODactivity were determined by ELISAmethod, and the expression ofHO-1, NQO1, Keap1, and nuclearNrf2was
assayed by western blotting. Results. Compared with saline-treated model group, both propofol and N-acetylcysteine pretreatment
can reduce the acute lung injury caused by orthotopic autologous liver transplantation (OALT), decrease the lung injury scores,
lung water content, and H
2
O
2
and MDA levels, and improve the arterial PaO
2
and SOD activity. Furthermore, propofol (but not
N-acetylcysteine) pretreatment especially in high dose inhibited the expression of Keap1 and induced translocation of Nrf2 into the
nucleus to further upregulate the expression of HO-1 and NQO1 downstream. Conclusion. Pretreatment with propofol is associated
with attenuation of OALT-induced ALI, and the Nrf2 pathway is involved in the antioxidative processes.
1. Introduction
ALI occurs after orthotopic liver transplantation (OLT) in
approximately 34.2% to 77.8% of cases [1, 2]. Moreover, ALI is
one of the main causes of death after OLT [3]. Some studies
have suggested that inflammation is themainmechanism and
therapeutic target of ALI induced by liver transplantation [4–
8]. Recent studies have shown that oxidative stress is another
important pathogenic mechanism of ALI [9]. However,
the status of oxidative stress in, and effects of antioxidant
therapy on ALI induced by liver transplantation are poorly
understood.
Propofol (2,6-diisopropylphenol) is one of the most
commonly used agents for use in either induction and
maintenance of anesthesia or sedation [10]. Apart from its
multiple anesthetic advantages, propofol exerts a number
of nonanesthetic effects [11]. Propofol has been shown to
enhance tissue antioxidant capacity in various tissues in a rat
model [12]. Also, recent studies have suggested that propofol
takes part in protection of various organs during acute injury.
Its cytoprotective properties might be related to antioxidative
stress [13] and anti-inflammatory response [14]. HO-1 has
been reported to be involved in the antioxidative mechanism
of propofol [15–18].
Nrf2 is a member of the Cap “n” Collar (CNC) family
of basic leucine zipper (bZip) transcription factors which
includes NF-E2, Bach1-2, and Nrf1-3 [19]. Nrf2 is a stress-
sensing genetic transcription factor which appears to be
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a master regulator of cellular responses to oxidative damage
and other stressful conditions.TheNrf2 antioxidant response
pathway is “the primary cellular defense against the cytotoxic
effects of oxidative stress” [20]. The transcriptional activity
and protein stability of Nrf2 are principally regulated by a
BTB-Kelch protein, Keap1, which has been shown to be a
substrate adaptor protein for the Keap1-cullin (Cul)3-Rbx1
E3 ubiquitin ligase complex, which, in turn, is responsible
for Nrf2 degradation [21]. Keap1 targets Nrf2 for ubiqui-
tination and subsequent degradation by proteasome. Like
other members of the CNC family of bZip transcription
factors, Nrf2 forms a heterodimer with its obligatory partner
Maf, thereby binding to a cis-acting enhancer sequence
known as the antioxidant response element (ARE). This
regulates the basal and inducible expression of genes that can
be grouped into several categories which include phase II
detoxifying enzymes, antioxidant genes, scavenger receptor,
chaperone proteins, transcription factors, and transporters
[22]. Furthermore, among the antioxidant and detoxification
enzymes, HO-1 is the most important one [23, 24]. Recent
studies have shown that activation of Nrf2 plays an important
role in acute lung injury both in vitro and in vivo [25, 26].
Nonetheless, Nrf2 antioxidant response in the process during
OALT-induced ALI remains unknown.
The aim of the current study was to determine whether
propofol could attenuate ALI, and if so, whether activation
of Nrf2 antioxidant response pathway was involved in a
rat model of liver transplantation “http://www.ncbi.nlm.nih
.gov/pubmed/24116032”
2. Methods and Materials
2.1. Animals and Establishment of the OALT Model. This
study was approved by the Animal Care Committee of the
Sun Yat-sen University and performed in accordance with
the National Institutes of Health guidelines for the use of
experimental animals [27]. A total of 40 pathogen-free, adult
male Sprague-Dawley rats (weighing 200–250 g)were housed
in individual cages in a temperature-controlled room with
alternating 12 h light/dark cycles. The rats were acclimated
for one week prior to experiments. Food was withheld 8 h
before the start of experiments, but all animals had free
access to water. Rats were anesthetized with pentobarbital
30mg/kg body weight, i.p. under 50% oxygen delivered by
animal mask. A standard model of OALT was created as
previously described [28]. The model simulates the main
pathophysiological processes during perioperative period of
liver transplantation. The anhepatic phase can be controlled
without the development of the complications of rejection or
other nonsurgical factors in orthotopic liver transplantation
using the cuff technique.
2.2. Animal Groups. The experimental animals were ran-
domly divided into five groups of eight rats each: sham:
celiotomy and vascular separation without OALT, treated
with saline (S), model (M), low-dose propofol (LP), high-
dose propofol (HP), and NAC groups (NAC). Groups S and
M were injected intraperitoneally in 3mL normal saline. for
3 consecutive days. Groups LP, HP, and NAC were injected
with propofol (Diprivan, propofol 1%, CG411, AstraZeneca,
Caponago, Italy. 50mg/kg, i.p. or propofol 100mg/kg, i.p.)
[29], and NAC (W508454. Sigma Aldrich (UK), 150mg/kg,
i.p.) [30] for three consecutive days. The last injection of
propofol occurred 12 h prior to operation. The rats in the
Group S were subjected to only celiotomy and vascular
separation under anesthesia. The rats in other groups were
subjected to OALT operation, including hepatic vascular
occlusion for 20 ± 1 min.
3. Tissue Sampling
The animals were anesthetized with chloral hydrate at 8 h
after OALT.The thorax was opened and lungs were removed.
The middle lobes of the right lung were weighed on an elec-
tronic scale, and the inferior lobes of right lung tissue were
fixed in 10% buffered formalin and embedded in paraffin for
histologic evaluation.The rest of the lung tissues were quickly
transferred in liquid nitrogen for storage for protein assays,
and for measuring H
2
O
2
andmalondialdehyde (MDA) levels
and SOD activity.
3.1. Arterial Blood Gas Analysis. The arterial blood partial
pressure of oxygen (PaO
2
) was measured in each lung sample
using an iSTAT portable blood gas analyzer (Abbott Labora-
tories, USA) according to the manufacturer’s instructions.
3.2. Lung Histologic Evaluation. The lung tissues were sec-
tioned (about 4mm thick) and stained with hematoxylin
and eosin (H&E). Two pathologists who were blinded to the
protocol analyzed the samples and scored the pathology as
described by Derks and Jacobovitz Derks [31]. The grade
of edema of the alveolar mesenchyme, intra-alveolar cell
infiltration, and alveolar hemorrhage was also scored.
3.3. Water Content of Lung. The wet weights of the superior
lobes of the right lungweremeasured, and the samples heated
at 80∘C for 24 h to reach a constant weight.The water content
of the lung was calculated: water content = (lung wet weight −
lung dry weight)/lung wet weight × 100 [32].
3.4.Western Blot Analysis. TheNrf2, Keap1,HO-1, andNQO1
proteins were detected by western blot analysis. The lung
tissues were finely homogenized, suspended in ice-cold lysis
buffer (1.5mL/g of tissue), and then centrifuged at 12,000 g
for 10min at 4∘C. The supernatants were recovered for
subsequent analysis. After measuring the protein concen-
trations of each sample, a 50 𝜇g of the protein sample was
solubilized in sodium dodecyl sulfate (SDS) loading buffer.
The samples were loaded into a 10% SDS polyacrylamide
gel, electrophoresed, and then transferred to a polyvinylidene
difluoride (PVDF) membranes. Finally, the PVDF mem-
branes were incubated with Nrf2 antibodies (1 : 250, sc-722,
Santa Cruze), Keap1 antibodies (1 : 1000, ABS97, Millipore),
HO-1 (1 : 250, sc-10789, Santa Cruz), or NQO1 (1 : 250, sc-
32793, Santa Cruz) followed by the corresponding secondary
antibodies. Protein-antibody complexes were detected with
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Figure 1: Pathological changes in the lungs after OALT. Group S: sham-operated group; Group M: saline-treated model group; Group LP:
low-dose propofol intervention group; Group HP: high-dose propofol intervention group. H&E staining; ×100. Bar graph quantifies the lung
histological scores. Data are presented as mean ± SD, with 𝑛 = 8 per group. (a) 𝑃 < 0.05 versus Group S; (b) 𝑃 < 0.05 versus Group M; (c)
𝑃 < 0.05 versus Group LP.
an enhanced chemiluminescence system (KGP1125, pur-
chased from Nanjing KeyGen Biotech. Co., Ltd.). Protein
band sizes were estimated using AlphaView software (Cell
Biosciences, Santa Clara, CA, USA). Anti-Histone H2A
(1 : 500, Santa Cruz, USA) and anti-𝛽-actin (1 : 1500, Merck
Milipore, Germany) were used to detect proteins levels. The
density measurement was correlated to the protein levels and
normalized to those of 𝛽-actin.
3.5. Detection of H
2
O
2
and MDA Levels and SOD Activity.
Lung tissues were prepared as 10% tissue homogenates, and
centrifuged at 3000 rpm at 4∘C for 10min. The supernatant
was collected for further analysis. The levels of H
2
O
2
were
measured using a kit (Keygen Biotech. Co., Ltd., Nanjing,
China). The MDA content was detected according to the
instructions of the MDA kit purchased from the Nanjing
Jiancheng Bioengineering Institute (Nanjing, China). The
SODactivity was detected according to the instructions of the
SOD Assay Kit (Keygen Biotech. Co., Ltd., Nanjing, China).
3.6. Statistical Analysis. All data were described as means ±
SD and analyzed using SPSS 13.0 software (SPSS, Chicago,
IL, USA). The differences between groups were analyzed by
one-way, ANOVA. Multiple comparisons were performed
by the Bonferroni procedure. Correlation between different
variables was assessed by Spearman’s coefficient. Differences
with 𝑃 < 0.05 were considered statistically significant.
4. Results
4.1. Light Microscopy of Lung Histology. Pathological mor-
phology of the lung following orthotopic autologous liver
transplantation was assessed using H&E staining. Lung
from the sham group (Group S) had normal morphology,
with minimal inflammatory cell infiltration (Figure 1(a)).
In Group M, there was infiltration of polymorphonuclear
and mononuclear inflammatory cells into the intra-alveolar
and interstitial spaces. This phenomenon was accompanied
by interstitial edema, and pulmonary architectural damage
(Figure 1(b)). However the ALI induced by OALT was signif-
icantly attenuated in rats pretreated with propofol, especially
at high doses and NAC (Figures 1(c)–1(e)), as shown by the
histopathological scores (Figure 1(f)).
4.2. Water Content and PaO
2
of Lungs. To quantitatively
assess the extent of pulmonary edema after OALT, the water
content of the middle lobe of the right lung was measured.
The lung water content was significantly higher in rats that
received OALT (Groups M, LP, HP, and NAC, 𝑃 < 0.05,
versus Group S), whereas the water content was lower in
rats pretreated with propofol or NAC compared with Group
M (Figure 2(a)). PaO
2
was measured to evaluate pulmonary
blood gas barrier dysfunction. PaO
2
was significantly higher
in Groups M, LP, HP, and NAC, 𝑃 < 0.05, versus Group S,
and lower in rats pretreated with propofol or NAC compared
with Group M (Figure 2(b)).
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Figure 2: Lung tissue water content (Figure 2(a)) and PaO
2
(Figure 2(b)) after OALT. Group S: sham-operated group; Group M: normal
saline control model group; Group LP: low-dose propofol intervention group; Group HP: high-dose propofol intervention group. Data are
presented as mean ± SD.(a) 𝑃 < 0.05 versus Group S; (b) 𝑃 < 0.05 versus Group M.
4.3. H
2
O
2
Levels, SOD Activity and MDA Levels in Lung
Tissue and Pathological Scores. H
2
O
2
is one of the main
reactive oxygen species (ROS) which can induce lipid per-
oxidation. Malondialdehyde (MDA) is the end product of
lipid peroxidation and can indirectly reflect the extent of
the radical attack on cells. Superoxide dismutase (SOD) can
protect cells from damage by elimination of oxygen free
radicals. It plays an important role inmaintaining the balance
between oxidation and antioxidation. As shown in Figure 3,
the levels of H
2
O
2
and MDA were significantly higher in rats
that received OALT compared with those in the sham group
(GroupsM, LP, HP, andNAC,𝑃 < 0.05, versus Group S).This
was accompanied by lower SOD activity. However, the levels
ofH
2
O
2
andMDAwere lower in rats pretreatedwith propofol
(especially high dose) or NAC compared with Group M.
This was accompanied by higher SOD activity. Studies have
shown thatNACcan significantly increase the activity of SOD
and scavenge ROS [33]. Also, MDA is a powerful biomarker
of oxidative stress in an organism. Its levels were positively
correlated with lung pathological scores (𝑟 = 0.7993; 𝑃 <
0.001), which indicates the important role of oxidative stress
in the pathophysiologic process of ALI induced by OALT. All
the above results suggest that propofol inhibits lung oxidative
stress after OALT in a dose-dependent manner.
4.4. Keap1 and Nuclear Nrf2 Expression in Lung Tissue. As
shown in Figure 4, the expression levels of Keap1 were lower
in rats that received OALT (Groups M, LP, HP, and NAC,
𝑃 < 0.05 versus Group S).The expression levels of Keap1 were
significantly lower in rats pretreated with propofol compared
with those in Group M (Group LP and HP; 𝑃 < 0.05 versus
GroupM).The levels of nuclear Nrf2 was significantly higher
in rats that received OALT (GroupsM, LP, HP, and NAC, 𝑃 <
0.05, versus Group S), and the expression was significantly
higher in rats pretreated with propofol compared with those
in Group M (Groups LP and HP, 𝑃 < 0.05, versus Group M).
However, the levels of Keap1 and nuclear Nrf2 in Group NAC
were not significantly different comparedwith those ofGroup
M.
4.5. HO-1 and NQO1 Expression in Lung Tissue. HO-1 and
NQO1 are regulated downstream by Nrf2. Measurement of
their expression can reflect the capacity of Nrf2 to regulate
antioxidants. As shown in Figure 5, the levels of HO-1 and
NQO1 were significantly higher in rats that received OALT
(Groups M, LP, HP, and NAC, 𝑃 < 0.05, versus Group S),
especially in rats pretreated with propofol (Groups LP and
HP, 𝑃 < 0.05, versus Group M).
5. Discussion
The main findings of the present experiments were that
propofol reduced the decline in oxygenation, pulmonary
edema (as assessed by increase in the W/D ratio), reactive
oxygen species (H
2
O
2
) and lipid peroxidation (MDA), and
histologic alteration induced by OALT through the Nrf2
antioxidant response pathway. To the best of our knowledge,
this is the first report showing that the antioxidant pathway
mediated by Nrf2 is associated with protective effect of
propofol (Figure 6) in ALI induced by liver transplantation.
Lung injury and respiratory failure often herald the
development of multiorgan dysfunction after liver transplan-
tation and other major surgeries. Systemic generation of ROS
during injurious insults impairs the pulmonary endothelium,
initiating deterioration in oxygenation [34]. Specifically, we
have previously shown that inflammation during OALT
increased alveolocapillary permeability in the lung [35], and
Nrf2 played an important role in antioxidative stress during
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Figure 3: H
2
O
2
levels, SOD activity, and MDA levels in lung tissue after OALT ((a), (b), and (c)). Correlations between MDA levels
and pathological scores (d). Group S: sham-operated group; Group M: normal saline control model group; Group LP: low-dose propofol
intervention group; Group HP: high-dose propofol intervention group. Data are presented as mean ± SD. (a) 𝑃 < 0.05 versus Group S;
(b) 𝑃 < 0.05 versus Group M; (c) 𝑃 < 0.05 versus Group LP.
OALT [36]. Based on these results, we investigated propofol
as a preventive agent because of its potent antioxidative stress
ability. Indeed, in the present study, the extent of the increase
of H
2
O
2
and MDA in the rabbits that underwent OALT
were reduced by propofol while SOD, HO-1, and NQO1 were
elevated. This result is similar to that reported by Vasileiou
et al. [37], who found that propofol could efficiently prevent
IIR-induced lung injury by reducing antioxidative stress. The
results are in contrast to the report by Kwak et al. which
demonstrated that propofol attenuates endotoxin-induced
ALI in rabbits mainly by inhibiting neutrophil and IL-8
responses in the inflammatory responses [38].
Nrf2 is ubiquitously expressed in various organs includ-
ing lung [39]. A previous study suggested that activation
of Nrf2 is involved in the prevention against ALI induced
by radiation and hyperoxia [40, 41]. And most studies have
documented that Nrf2 is a key regulatory transcription
factor for inducing antioxidant and detoxification genes [42].
Upregulation of Nrf2 can promote the synthesis of various
antioxidant enzymes that protect against the adverse effects of
oxidative stress induced by ROS [43]. Conversely, downregu-
lation of Nrf2makes the organismmore sensitive to oxidative
stress induced by ROS [44]. Using in vivo study, Nrf2
knockout mice were found to be more susceptible to injury
and tumorigenesis in response to oxidative and chemical
stress [45]. Nrf2 is activated following its detachment from
Keap1 and then translocated to the nucleus where it binds to
the ARE in the promoter region of target genes, leading to
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their transcriptional induction. Endogenous antioxidants are
activated, and ROS are scavenged to reduce oxidative damage
[43]. There are more than 200 genes that have been shown to
be regulated by the Nrf2/ARE pathway. These genes encode
phase II detoxification enzymes and antioxidant proteins,
including NQO1 and HO-1 [42]. HO-1 is an enzyme that cat-
alyzes the breakdown of heme into the antioxidant biliverdin,
the anti-inflammatory agent carbonmonoxide, and iron [46].
NQO1 is an enzyme that, in humans, is encoded by the
NQO1 gene. The enzymatic activity of this protein prevents
the one-electron reduction of quinones that results in the
production of free radical species [47]. In the present study,
Nrf2 antioxidant response pathwaywas activated by oxidative
stress duringOALT-inducedALI.However, the levels ofNrf2,
HO-1, andNQO1 apparently were insufficient to prevent lung
oxidative damage induced by OALT, as serious lung injury
still occur. These results indicate that enhanced antioxidant
activity mediated by Nrf2 can reduce oxidative injury.
Mounting evidence has shown that propofol can reduce
remote organ ischemia/reperfusion injury through its antiox-
idant effect [37, 48]. However, the mechanisms of propofol
effects on various antioxidants remain to be identified. The
protective role of propofol is probably mostly related to its
preischemic administration, since postischemic administra-
tion has not been found effective [49]. This could be either
due to adequate concentrations of propofol locally in the lung
tissue and systemic circulation at the onset of reperfusion
or also due to a protective effect during ischemia. In order
to prove the influence of propofol on the Nrf2 pathway, we
chose another antioxidant NAC as control. The effect of ALI
induced by OALT in the presence and absence of NAC on
nuclear Nrf2 was evaluated, with inhibition of this process by
NAC taken as evidence that the process was redox mediated.
We found that propofol efficiently enhanced the activities
of antioxidant enzymes mediated by Nrf2, which was char-
acterized by the downregulation of Keap1 expression and
upregulation of nuclear Nrf2, HO-1, and NQO1 expression.
Also, the activity of SODwas increased and oxidative damage
in injured lung was significantly reduced when rats were
pretreatedwith propofol especially in high dose. Interestingly,
we also found that NAC could increase SOD activity but
cannot activate Nrf2 pathway, which suggested that NAC
played a role antioxidant mainly through improving activity
of SOD rather than activating Nrf2 pathway. This result is
similar to the report by Messier et al. who suggested that
the NAC cytoprotective effect is independent of nuclear Nrf2
[50]. Taken together, our results suggest that propofol is a
potential Nrf2 strong activator.
There are some limitations in this study. Although we
found that propofol activation of the Nrf2 pathway prevents
OALT-induced ALI, we did not investigate whether propofol
could still be protective in the presence of downregulation
of Nrf2 expression. Such studies are planned in the future.
Future studies will be directed at the activation and roles of
Nrf2 pathways after propofol preconditioning of the lung.
Treatment initiated after the onset of ischemia or during
reperfusion due to unexpected occurrence of I/R event is also
an area of proposed future study.
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In conclusion, we found that Nrf2-mediated defense
mechanisms are involved in the antioxidant ability of propo-
fol against the adverse effects of acute lung oxidative injury
induced by OALT. In the future, specific target sites of
propofol involvement in the Nrf2 pathway, and optimization
of treatment for ALI induced by liver transplantation will be
studied.
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